Seeking Alpha
09 Jun 2026, 13:44 UTC · 1h ago
TransMedics: Why I'm Still Bullish After The Collapse
Seeking Alpha
09 Jun 2026, 13:44 UTC · 1h ago
Story key points
4 claims · impact-rated
TransMedics' revenue growth has decelerated from the 40-50% range to 20-25%. — A significant slowdown in growth rates typically leads to valuation multiple compression for high-growth healthcare companies.
-0.60Logistics and clinical services now comprise nearly 40% of the company's revenue. — Diversification into services creates a more sustainable competitive moat and provides long-term margin support.
+0.40The company is experiencing compressed margins due to increased investment and normalizing growth. — Short-term margin pressure indicates higher operational costs and potential earnings misses.
-0.30The current valuation stands at 4x EV/Sales. — A lower valuation multiple may attract value-oriented investors despite the growth slowdown.
Continue reading
6 related stories
Top 3 movers · tap to explore
Ticker attribution
Model heads
Despite decelerating growth and margin pressure, the analyst maintains a bullish outlook and a buy rating due to strong market share and attractive valuation.
No ticker relationship head found.
Early access
Unlock the full impact breakdown — and whether these names are in a Stage 2 uptrend right now. Free account, 30 seconds.
No credit card. Cancel anytime.
Browse live screeningsImpact vectors
1 dimensions · 9 clusters
Market reaction
0 bid · 10 offered
No stock impact ranking available yet.
Screener bridge
Catch the names this kind of story moves — before the chart does.
Get the full NIS Momentum results every Friday at 4PM ET — free via email or Telegram.
Invezz
1h ago
